373 related articles for article (PubMed ID: 9464239)
21. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families.
Malloy PJ; Hochberg Z; Tiosano D; Pike JW; Hughes MR; Feldman D
J Clin Invest; 1990 Dec; 86(6):2071-9. PubMed ID: 2174914
[TBL] [Abstract][Full Text] [Related]
22. The BsmI vitamin D receptor restriction fragment length polymorphism (bb) influences the effect of calcium intake on bone mineral density.
Kiel DP; Myers RH; Cupples LA; Kong XF; Zhu XH; Ordovas J; Schaefer EJ; Felson DT; Rush D; Wilson PW; Eisman JA; Holick MF
J Bone Miner Res; 1997 Jul; 12(7):1049-57. PubMed ID: 9200004
[TBL] [Abstract][Full Text] [Related]
23. The contribution of vitamin D receptor gene polymorphisms in osteoporosis and familial osteoporosis.
Fountas L; Moutsatsou P; Kastanias I; Tamouridis N; Tzanela M; Anapliotou M; Sekeris CE
Osteoporos Int; 1999; 10(5):392-8. PubMed ID: 10591837
[TBL] [Abstract][Full Text] [Related]
24. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.
Dunlop TW; Väisänen S; Frank C; Molnár F; Sinkkonen L; Carlberg C
J Mol Biol; 2005 Jun; 349(2):248-60. PubMed ID: 15890193
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets.
Lin NU; Malloy PJ; Sakati N; al-Ashwal A; Feldman D
J Clin Endocrinol Metab; 1996 Jul; 81(7):2564-9. PubMed ID: 8675579
[TBL] [Abstract][Full Text] [Related]
26. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
Peräkylä M; Malinen M; Herzig KH; Carlberg C
Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
[TBL] [Abstract][Full Text] [Related]
27. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor polymorphisms, bone mineral density, and bone metabolism in postmenopausal Mexican-American women.
McClure L; Eccleshall TR; Gross C; Villa ML; Lin N; Ramaswamy V; Kohlmeier L; Kelsey JL; Marcus R; Feldman D
J Bone Miner Res; 1997 Feb; 12(2):234-40. PubMed ID: 9041055
[TBL] [Abstract][Full Text] [Related]
29. Presence of gene expression of vitamin D receptor and 24-hydroxylase in OK cells.
Ishimura E; Shoji S; Koyama H; Inaba M; Nishizawa Y; Morii H
FEBS Lett; 1994 Jan; 337(1):48-51. PubMed ID: 8276112
[TBL] [Abstract][Full Text] [Related]
30. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
31. Expression of the 1,25-dihydroxyvitamin D3-24-hydroxylase gene in rat intestine: response to calcium, vitamin D3 and calcitriol administration in vivo.
Lemay J; Demers C; Hendy GN; Delvin EE; Gascon-Barré M
J Bone Miner Res; 1995 Aug; 10(8):1148-57. PubMed ID: 8585417
[TBL] [Abstract][Full Text] [Related]
32. 1,25-dihydroxyvitamin D resistance, rickets, and alopecia: analysis of receptors and bioresponse in cultured fibroblasts from patients and parents.
Chen TL; Hirst MA; Cone CM; Hochberg Z; Tietze HU; Feldman D
J Clin Endocrinol Metab; 1984 Sep; 59(3):383-8. PubMed ID: 6086691
[TBL] [Abstract][Full Text] [Related]
33. The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
Nguyen TM; Lieberherr M; Fritsch J; Guillozo H; Alvarez ML; Fitouri Z; Jehan F; Garabédian M
J Biol Chem; 2004 Feb; 279(9):7591-7. PubMed ID: 14665637
[TBL] [Abstract][Full Text] [Related]
34. 1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin.
Li XY; Boudjelal M; Xiao JH; Peng ZH; Asuru A; Kang S; Fisher GJ; Voorhees JJ
Mol Endocrinol; 1999 Oct; 13(10):1686-94. PubMed ID: 10517670
[TBL] [Abstract][Full Text] [Related]
35. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women.
Tokita A; Matsumoto H; Morrison NA; Tawa T; Miura Y; Fukamauchi K; Mitsuhashi N; Irimoto M; Yamamori S; Miura M; Watanabe T; Kuwabara Y; Yabuta K; Eisman JA
J Bone Miner Res; 1996 Jul; 11(7):1003-9. PubMed ID: 8797122
[TBL] [Abstract][Full Text] [Related]
36. Regulation of intestinal vitamin D receptor expression in experimental uraemia: effects of parathyroidectomy and administration of PTH.
Szabó A; Schmutz A; Pesian S; Schmidt-Gayk H; Ritz E; Reichel H
Nephrol Dial Transplant; 1998 Feb; 13(2):340-9. PubMed ID: 9509444
[TBL] [Abstract][Full Text] [Related]
37. A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia.
Malloy PJ; Xu R; Peng L; Clark PA; Feldman D
Mol Endocrinol; 2002 Nov; 16(11):2538-46. PubMed ID: 12403843
[TBL] [Abstract][Full Text] [Related]
38. [Study on the relationship between some genetic factors and peak bone mineral density in Beijing young women].
Yang X; Zheng SR; Chen RJ; Chen SL; Fan ZH; Li H; Lu YH
Zhonghua Fu Chan Ke Za Zhi; 2003 May; 38(5):273-6. PubMed ID: 12895309
[TBL] [Abstract][Full Text] [Related]
39. [Effect of vitamin D receptor gene polymorphism on vitamin D therapy for postmenopausal bone loss].
Owada M; Suzuki K; Honda T; Yamada H; Tsukikawa S; Hoshi K; Sato A
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):799-805. PubMed ID: 8841046
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.
Ban Y; Taniyama M; Ban Y
J Clin Endocrinol Metab; 2000 Dec; 85(12):4639-43. PubMed ID: 11134121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
